Menu
Speaker: Frank Aviles Jr, PT, CWS, FACCWS, CLT-LANA, ALM, AWCC, DAPWCA
Date and Time: Feb 17, 2022, 12:10 PM in EST, CST, MST and PST (Four presentations)
Frank Aviles Jr. Bio
Frank is currently the Wound Care Clinical Coordinator at Natchitoches Regional Medical Center (NRMC) overseeing and assisting with wound care practices across the continuum of care. He has over 30 years of wound care experience and has multiple roles as a wound specialist, lymphedema therapist, hyperbaric technician, physical therapist, consultant, and educator.
Frank is also involved with Louisiana Extended Care Hospital Natchitoches, LHC group, the Academy of Lymphatic Studies, Cane River Therapy Services, industry, Virtual Wound Rounds and Wound Healing Roundtables.
He has been an American Physical Therapy Association (APTA) member since 1990, is a board certified wound specialist, a fellow of the American College of Certified Wound Specialists, a certified lymphedema therapist, advanced wound care certified, currently serves as the practice chair for the Special Interest Group section of the Academy of Clinical Electrophysiology and Wound Management Section of the APTA, is on the Why Wound Care Advisory Board for HMP Global, is on the editorial board for Today’s Wound Clinic, Today’s Wound Clinic – “Let’s Be Frank” columnist, is a board member for Community Healthcare Education Network (CHEN), is on the board of directors for the American Professional Wound Care Association (APWCA), advisory board member for Wound Source, education committee member for the American College of Certified Wound Specialist (ACCWS) , board member for the Save a Leg Save a Life Foundation (SALSAL), and planning committee for the Symposium of Advanced Wound Care (SAWC).
Kerecis®️, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection, has received authorization from the FDA to market Kerecis Omega3 SurgiBind™️. The product, which is available now in the United States, is an implantable fish-skin graft for use in plastic and reconstructive surgery. The product is indicated for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair, or reinforcement in plastic or reconstructive surgery.
© 2010-2024 Kerecis. All Rights Reserved
